Category: N.1 March 2023 1-120

Due pazienti fragili in Pronto Soccorso: il ruolo del laboratorio nel monitoraggio della terapia con anticoagulanti orali ad azione diretta
Two frail patients in the Emergency Room: the laboratory role in the monitoring of the direct anticoagulants therapy[]

A rare case of gamma heavy-chain disease highlighting the need of a comprehensive evaluation of laboratory data[]

Grandi novità per LTO nel 2023[]

Standardizzazione e armonizzazione dell’albuminuria: a che punto siamo?[]

Variability of cardiac troponin levels in normal subjects and in patients with cardiovascular diseases: analytical considerations and clinical relevance. A consensus document by the Study Group on Cardiac Biomarkers from Italian Society of Biochemical Chemistry (SIBioC) and European Ligand Assay Society (ELAS)[]

La nuova equazione Chronic Kidney Disease Epidemiology Consortium (CKD-EPI) senza la correzione per l’etnia per la stima del filtrato glomerulare: è applicabile in Europa? La posizione della European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
The new, race-free, Chronic Kidney Disease Epidemiology Consortium (CKD-EPI) equation to estimate glomerular filtration rate: is it applicable in Europe? A position statement by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)[]

Indicazioni per l’armonizzazione degli intervalli di riferimento nel monitoraggio terapeutico di farmaci antiepilettici
Recommendations for the harmonization of reference intervals in the therapeutic monitoring of antiepileptic drugs[]

Big data e intelligenza artificiale in medicina di laboratorio
Artificial intelligence and big data in laboratory medicine[]

Impact on laboratory medicine of transitioning from COVID-19 pandemic to “tripledemic”[]

A “special dose” of ethics in forensic toxicology[]